related symptoms and exhibited strenuous breathing patterns, and about 33 percent of them developed blood clots. Every participant was given treatment including supportive measures in medical therapy such as a wearable or implantable cardioverter-defibrillator. These procedures resulted in the improvement of cardiac performance and symptoms related to heart damage in those who stopped using meth.
Additionally, participants who stopped using the drug decreased their likelihood of an earlier death, rehospitalization for related issues, and non-fatal strokes in comparison to those who continued using meth during the medical treatment provided by the researchers — 57 percent versus 13 percent, respectively.
